Bjorn is a partner in the Finance Group and resident in the New York office. His practice is focused on representing borrowers, lenders, managers and investors in a broad range of complex financing arrangements including securitizations and other structured financings, acquisition financings and leveraged loans, repo facilities, commodity, equity, credit and fund linked derivatives. In addition, he has extensive experience representing investors, creditors and managers in complex restructurings, work-outs and acquisitions of distressed and non-performing assets. He is involved in all aspects of deal structuring, negotiation and documentation.

• Jefferies Finance LLC in connection with various high yield bond offerings
• Jefferies Finance LLC in connection with various revolver CLOs with senior and junior VFN tranches and mezzanine funded tranches
• Mizuho Securities (USA) in connection with a bridge financing to Sprint Communications, Inc. and a sale-lease-back spectrum financing transaction with Sprint
• Mizuho Securities (USA) in connection with a term loan facility to Evercore Partners Inc.
• OneMain Financial in connection with the securitization of consumer financing loan
• Advent International and Oberthur Technologies in the market leading refinancing of Oberthur’s senior bank debt with a New York law covenant-lite Term Loan B credit facility consisting of a (i) a €260 million term loan tranche; (ii) a $280 million term loan tranche; and (iii) a €88 million revolving credit facility, arranged by J.P. Morgan Securities LLC, Goldman Sachs International, Lloyds Securities Inc., Barclays Bank Plc, HSBC France and Société Générale S.A., with JPMorgan Chase Bank, N.A. as administrative agent
• Juniper Investment Company as purchaser and borrower in connection with a senior secured financing, including an asset-based revolving credit facility and a term loan, related to the acquisition of Theragenics Corporation arranged by Credit Suisse Loan Funding
• Bank of America, N.A. in connection with a $3.1 billion sale and repurchase agreement financing transaction related to Amgen Inc.’s $10.5 billion purchase of Onyx Pharmaceuticals Inc. Concurrently, the firm also represented Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Bank PLC and J.P. Morgan Securities LLC as joint lead arrangers and joint bookrunning managers in connection with a $5 billion term loan related to the acquisition
• Advice to U.S. and non-U.S. financial institutions in connection with U.S. regulatory reform affecting derivatives and structured products, including compliance with various Dodd-Frank Act requirements
• Advice to U.S. and non-U.S. financial institutions in connection with derivatives transaction close-out and counterparty risk management for derivatives transactions
• Documenting various derivatives, repurchase agreements, margin loans and other securities contracts
• Documentation and structuring of various synthetic trading arrangements
• Advice to managers, counterparties, lenders and board members on a wide range of restructuring, liquidations and investments in CDOs, CLOs and other structured financing arrangements
• Documentation of structured securities lending transactions for financial institution counterparties
• Representing managers and lenders in connection with a variety of bankruptcy remote structures
• Representing managers and lenders in various fund liquidity facilities, including subscription line facilities